V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 270014810 | 270010627 | 1.68 | 71.8 | Palliative (P) | 2016-01-22 | 2016-04-13 | NHL 2003 Gp B COPADM 1 & 2 | N | N | 270024216 | LACE |
| 270014811 | 270010627 | 1.79 | 66 | Curative (C) | 2014-07-30 | 2014-07-30 | DHAP - R | N | N | 270024216 | ICE |
| 270014812 | 270010628 | 1.71 | null | Neo-adjuvant (N) | 2015-10-21 | 2015-10-21 | Ifosfamide | N | N | 270024266 | CYCLOPHOSPHAMIDE |
| 270014813 | 270010629 | 1.63 | 45 | Curative (C) | 2017-01-28 | 2017-01-28 | PACLITAXEL | N | N | 270024270 | BORTEZOMIB + THALIDOMIDE |
| 270014814 | 270010632 | null | 65 | Curative (C) | 2014-12-15 | 2015-01-05 | Alemtuz+Fludara+Melphalan RIC MUD | 99 | null | 270024285 | CYCLOPHOSPHAMIDE |
| 270014815 | 270010632 | 1.9 | 110 | Curative (C) | 2016-05-15 | 2016-05-21 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | null | N | 270024285 | MELPHALAN |
| 270014816 | 270010632 | 1.87 | 89 | null | 2018-02-12 | 2018-03-19 | Etoposide IV | N | N | 270024285 | OXALIPLATIN + MDG + PANITUMUMAB |
| 270014817 | 270010632 | 1.73 | 52.7 | Curative (C) | 2016-12-23 | 2016-12-31 | METHOTREXATE | 02 | N | 270024285 | IBRUTINIB |
| 270014818 | 270010632 | null | 100 | Disease modification (D) | 2015-04-08 | 2015-04-14 | Nilotinib | N | Y | 270024285 | CYCLOPHOSPHAMIDE |
| 270014819 | 270010634 | 0 | 83.6 | Neo-adjuvant (N) | null | 2014-07-22 | ECHELON 1 TRIAL | 2 | N | 270024329 | ICE |
| 270014820 | 270010634 | 1.64 | null | Adjuvant (A) | 2015-02-13 | 2015-02-15 | ICE (no GCSF) | N | N | 270024329 | GDP R |
| 270014821 | 270010634 | 1.68 | null | Curative (C) | 2016-06-13 | 2016-08-10 | CVP R | N | null | 270024329 | GEMCITABINE + VINORELBINE |
| 270014822 | 270010636 | 1.66 | 65 | Palliative (P) | 2014-06-24 | 2014-06-28 | RATHL TRIAL | N | N | 270024461 | CVP R |
| 270014823 | 270010637 | 1.76 | 83 | Adjuvant (A) | 2014-04-04 | 2014-04-04 | ETOPOSIDE | 2 | N | 270024473 | CARMUSTINE + THIOTEPA |
| 270014824 | 270010638 | 1.75 | 83.2 | Curative (C) | 2013-11-29 | 2013-12-12 | LENALIDOMIDE | 02 | N | 270024473 | BLEOMYCIN |
| 270014825 | 270017255 | 1.61 | 69.5 | Curative (C) | 2015-06-04 | 2015-06-18 | RATHL TRIAL | 02 | N | 270024501 | ARSENIC TRIOXIDE |
| 270014826 | 270010640 | null | null | null | 2017-07-18 | 2017-07-19 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | 02 | N | 270024510 | CLADRIBINE |
| 270014827 | 270010643 | 1.76 | 67.3 | Curative (C) | 2013-04-28 | 2013-05-11 | BLEOMYCIN | N | null | 270024518 | METHOTREXATE INTRATHECAL |
| 270014828 | 270010646 | 1.7 | 72.8 | Curative (C) | 2014-12-15 | 2015-01-05 | BENDAMUSTINE + CYTARABINE + ETOPOSIDE + MELPHALAN | 02 | N | 270024537 | METHOTREXATE INTRATHECAL |
| 270014829 | 270010647 | 1.6 | null | Curative (C) | 2017-01-12 | 2017-01-26 | Gemcitabine + Oxaliplatin | null | N | 270024541 | CYCLOPHOSPHAMIDE + GEMCITABINE + VINCRISTINE |
| 270014830 | 270014972 | 1.75 | null | Curative (C) | 2013-11-24 | 2013-12-08 | ECHELON 1 TRIAL | N | N | 270024541 | IDELALISIB + RITUXIMAB |
| 270014831 | 270010650 | 1.74 | null | Curative (C) | 2016-11-20 | 2017-04-17 | GEMCITABINE + OXALIPLATIN + RITUXIMAB | N | null | 270024586 | RATHL TRIAL |
| 270014832 | 270014973 | 1.78 | 58.4 | Curative (C) | 2015-01-16 | 2015-01-23 | CARBOPLATIN + GEMCITABINE | N | Y | 270024596 | PACLITAXEL |
| 270014833 | 270010651 | null | null | Palliative (P) | null | 2017-02-28 | FLUOROURACIL + OXALIPLATIN + PANITUMUMAB | null | null | 270024611 | DOXORUBICIN |
| 270014834 | 270010652 | 1.68 | 53.4 | Neo-adjuvant (N) | 2015-07-14 | 2015-08-22 | CHLORAMBUCIL + ETOPOSIDE + LOMUSTINE | N | N | 270024611 | BENDAMUSTINE + RITUXIMAB |
| 270014835 | 270010654 | 1.92 | 90.3 | Disease modification (D) | 2017-05-21 | 2017-05-22 | CARBOPLATIN + CETUXIMAB + FU | N | N | 270024614 | CYCLOPHOSPHAMIDE |
| 270014836 | 270010655 | 1.64 | null | Disease modification (D) | 2015-04-28 | 2015-05-11 | CHLVPP PABLOE | N | null | 270024651 | CYCLOPHOSPHAMIDE |
| 270014837 | 270010655 | 1.72 | 86.6 | Palliative (P) | 2017-07-28 | 2017-08-04 | CVP | N | null | 270024651 | ICE |
| 270014838 | 270010655 | null | null | Palliative (P) | 2015-02-19 | 2015-02-25 | Dacarbazine | N | N | 270024651 | CHOP |
| 270014839 | 270010658 | 1.78 | 94 | Palliative (P) | 2017-08-26 | 2017-09-07 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN | 2 | N | 270024685 | DHAP - R |
| 270014840 | 270014977 | 1.78 | 86.5 | Curative (C) | null | 2016-08-28 | Dacarbazine | null | null | 270024705 | DOXORUBICIN |
| 270014841 | 270010659 | 1.51 | 140.4 | Not known (9) | 2014-11-29 | 2014-12-06 | CHLVPP PABLOE | N | N | 270024728 | IMATINIB |
| 270014842 | 270010659 | 1.75 | null | Palliative (P) | 2018-07-08 | 2018-07-08 | Gemcitabine + Oxaliplatin | N | N | 270024728 | DHAP - R |
| 270014843 | 270010659 | 1.8 | 77.9 | Neo-adjuvant (N) | 2015-09-16 | 2015-09-16 | Fludarabine + Melphalan RIC Allo | 2 | N | 270024728 | IFOSFAMIDE |
| 270014844 | 270010661 | 1.71 | 61.8 | Curative (C) | 2014-11-18 | 2014-11-18 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | N | N | 270024751 | ALEMTUZUMAB + FLUDARABINE + MELPHALAN |
| 270014845 | 270010662 | 1.67 | 0 | Palliative (P) | 2017-03-07 | 2017-03-10 | PACLITAXEL | 02 | N | 270024754 | CYCLOPHOSPHAMIDE + ETOPOSIDE + PROCARBAZINE |
| 270014846 | 270010664 | 1.7 | 122.3 | Adjuvant (A) | 2015-08-12 | 2017-11-27 | VINCRISTINE | N | N | 270024754 | GEMCARBO |
| 270014848 | 270010668 | 1.72 | 112.3 | Curative (C) | 2018-10-15 | 2018-10-29 | Methotrexate intrathecal | N | N | 270024790 | ICE-R |
| 270014849 | 270010672 | 1.71 | 52 | Palliative (P) | 2018-12-23 | 2018-12-23 | IDELALISIB + RITUXIMAB | 2 | N | 270024801 | BLEOMYCIN |
| 270014850 | 270010673 | 1.62 | 61 | Curative (C) | 2013-10-03 | 2013-10-03 | Methotrexate intrathecal | N | N | 270024801 | CYCLOPHOSPHAMIDE |
| 270014851 | 270010674 | null | 89 | Curative (C) | 2016-12-26 | 2016-12-26 | Alemtuz+Fludara+Melphalan RIC MUD | N | N | 270024824 | HYDROXYCARBAMIDE |
| 270014852 | 270017264 | 1.62 | 0 | Curative (C) | 2015-02-15 | 2015-03-01 | METHOTREXATE | 02 | N | 270024861 | GEMCARBO |
| 270014853 | 270010675 | 1.76 | 86 | Curative (C) | 2015-06-15 | 2015-06-16 | CHLVPP PABLOE | N | N | 270024867 | RATHL TRIAL |
| 270014854 | 270010676 | null | 67.7 | Disease modification (D) | 2014-11-27 | 2014-11-28 | VINCRISTINE | 2 | N | 270024871 | METHOTREXATE INTRATHECAL |
| 270014855 | 270010677 | 1.76 | 117 | Palliative (P) | 2017-12-13 | 2017-12-13 | CVP | 2 | N | 270024883 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |
| 270014856 | 270014985 | 1.75 | 58 | Not known (9) | 2018-02-25 | 2018-02-27 | FLUDARABINE | N | N | 270024883 | CYCLOPHOSPHAMIDE |
| 270014857 | 270019300 | null | null | Curative (C) | null | 2017-05-05 | DACARBAZINE + DOXORUBICIN + VINBLASTINE | null | null | 270024893 | LOPP |
| 270014858 | 270017266 | null | 74.9 | Palliative (P) | 2015-11-18 | 2015-11-23 | CVP R | 02 | N | 270024900 | CYCLOPHOSPHAMIDE |
| 270014859 | 270019301 | 1.79 | 66.7 | Curative (C) | 2017-04-05 | 2017-04-19 | CHLVPP PABLOE | 02 | N | 270024906 | METHOTREXATE INTRATHECAL |
| 270014860 | 270019301 | null | null | Curative (C) | null | 2016-07-30 | ICE | null | null | 270024906 | DACARBAZINE + DOXORUBICIN + VINBLASTINE |